On Thursday, Alder Biopharmaceuticals Inc (NASDAQ:ALDR)’s shares declined -0.32% to $40.83.
Alder BioPharmaceuticals, Inc. (ALDR), a clinical-stage biopharmaceutical company, declared recently that the underwriters of its formerly declared public offering of common stock have exercised in full their option to purchase an additional 674,157 shares of common stock. The closing of the sale of all shares occurred recently. Gross proceeds from the offering of an aggregate of 5,168,539 shares at a public offering price of $44.50 per share, before underwriting discounts and commissions and offering expenses, were about $230 million.
Credit Suisse, Leerink Partners and Wells Fargo Securities acted as joint book-running managers for the offering. Bernstein acted as co-manager for the offering.
Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes various therapeutic antibodies in the United States and Australia. It is developing monoclonal antibodies comprising ALD403, which has accomplished Phase Ib proof-of-concept trials to target calcitonin gene-related peptide for the prevention of migraine; Clazakizumab that has accomplished Phase IIb clinical trials that inhibits the pro-inflammatory cytokine interleukin-6 in the treatment of rheumatoid arthritis and psoriatic arthritis; and ALD1613, which is in preclinical stage of development for the treatment of Cushing’s disease.
Dr Pepper Snapple Group Inc. (NYSE:DPS)’s shares gained 0.56% to $75.96.
Dr Pepper Snapple Group, Inc., (DPS) has reached a contract to make an equity investment in BA Sports Nutrition, LLC, owner of BODYARMOR SuperDrink, a line of premium sports drinks. The $20 million investment gives DPS an 11.7 percent ownership position in BA Sports Nutrition.
DPS has carried BODYARMOR as an allied brand in much of its direct store delivery network since 2013 and plans to expand the product line further in its system over the next year.
Dr Pepper Snapple Group, Inc. operates as a brand owner, manufacturer, and distributor of non-alcoholic beverages in the United States, Canada, Mexico, and the Caribbean. The company operates through three segments: Beverage Concentrates, Packaged Beverages, and Latin America Beverages. It offers flavored carbonated soft drinks (CSDs) and non-carbona
At the end of Thursday’s trade, Varonis Systems Inc (NASDAQ:VRNS)‘s shares dipped -10.35% to $17.67.
Loyola University Maryland has been named as a 2015 Computerworld Data+ Editors’ Choice Award honoree for its use of Varonis (VRNS), the leading provider of software solutions for unstructured, human-generated enterprise data. This prestigious honor recognizes innovative big data initiatives that have delivered noteworthy business value.
Loyola University Maryland feared the possibility of falling victim to a fate that other major universities around them had practiced: a major data breach. In the months following the early 2014 attack on a major university nearby, Loyola’s CIO, Louise Finn, proactively explored various solutions that could mitigate risk in the event of a similar attack, but the technologies she probed could not provide reliable and detailed insights. That’s when Finn and her IT team discovered Varonis Systems, Inc. and its DatAdvantage solution. Now, with Varonis, Loyola is able to track all access to data and assess it against baseline end-user activity and know when abnormal behaviors occur.
Varonis Systems, Inc. provides software platform for enterprises to map, analyze, manage, and migrate their unstructured data. Its Metadata Framework technology platform extracts critical metadata, or data about data, from an organization’s IT infrastructure and uses this contextual information to map functional relationships among employees, data objects, content, and usage.
Sun Life Financial Inc (NYSE:SLF), ended its Thursday’s trading session with 3.39% gain, and closed at $32.04.
Sun Life Financial Inc. (SLF.TO) (SLF) recently declared a contract with Assurant, Inc. (Assurant) (AIZ) to acquire Assurant’s Employee Benefits business for a net investment of US$975 million .1 The transaction will create the sixth largest group benefits business in the U.S., with the combined business having one of the broadest product portfolios in the industry.
“The acquisition of the Assurant Employee Benefits business is directly on strategy, accelerating the growth of our U.S. Group Benefits business and expanding the scope of our benefits business in North America ,” said Dean Connor , President and Chief Executive Officer of Sun Life Financial. “The transaction is another example of how we are deploying capital effectively across all four pillars of growth to create long-term value for shareholders of Sun Life Financial.”
The transaction will add noteworthy new capabilities to the Sun Life U.S. Group Benefits business, counting a strong Dental business with the second largest proprietary provider network in the U.S. The transaction also comprises a successful Group Life and Disability business, and adds strong Voluntary products and capabilities, Vision products and unique client technology. Also comprised of is the Disability RMS business, which is the leader in partnering with other insurers to offer Disability products.2
The transaction will significantly enhance the size and scale of the Sun Life U.S. Group Benefits business, growing business in-force by more than 50% to about US$4 billion 3, strengthening the company’s partnerships with brokers and private exchanges and supporting investments in technology and distribution.
Sun Life Financial Inc., a financial services organization, provides protection and wealth products and services to individuals and corporate customers worldwide. It operates through Sun Life Financial Canada, Sun Life Financial United States, MFS Investment Administration, and Sun Life Financial Asia segments.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.